Sarepta Therapeutics Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980, the company maintains some laboratory capability in Corvallis, Oregon. As of 2014, the company does not commercialize any approved drug. As of 2008, Sarepta has 170 issued medical patents, and over 150 patents pending. The company changed its name from AVI BioPharma and stock symbol from AVII in July 2012 to Sarepta Therapeutics and SRPT respectively.
NPS is a customer loyalty metric that measures customers’ willingness to not only return for another purchase or service but also make a recommendation to their family, friends or colleagues.
It is a powerful and effective technique, which can greatly increase a company's revenue if used properly.
The main advantages of NPS are close correlation with a company's growth and easy collection, interpretation and communication of the data.
Net Promoter Score is a number from -100 from 100.
Scores higher than 0 are typically considered to be good and scores above 50 are considered to be excellent.
The industry average for Health Care / Major Pharmaceuticals is 0.
The final Net Promoter Score of a company strongly depends on a context in which the satisfaction is measured.
Consider an example: If Sarepta Therapeutics, Inc. sends out NPS surveys immediately after purchase, they are tracking their customers' initial excitement and the checkout experience.
On the other hand, if they survey their customers a few weeks after the purchase they are also tracking how satisfied their customers are with their products and services over time.
Therefore, comparing the NPS score of Sarepta Therapeutics, Inc. with your own without any further context is not that useful.
What is extremely useful though, is using the NPS methodology to track the satisfaction of your customers over time. That's where Customer.guru comes in.
|CIGNA||Insurance / Health and Life Insurance||-1|
|Vodafone||Telecommunications / Wireless Carrier||-1|
|Chase||Financial Services / Banking||-1|
|Cleeng||Technology / Software||1|
|Fifth Third Bank||Financial Services / Banking||1|
|Accenture Consulting||Technology / Other||1|
|Dish||Telecommunications / Cable/TV service||1|
|Morrisons||Consumer Brands / Grocery||2|
|Mediacom||Consumer Brands / Entertainment||2|
|ESPN||Consumer Brands / Entertainment||2|
We have estimated the Net Promoter Score of Sarepta Therapeutics, Inc. based on the publicly available information
including the sentiment of the company-related tweets, 3rd party reviews, and Alexa ratings.